Authors

• Helmut Pürerfellner (ORCID: https://orcid.org/0000-0002-8965-8495)
• Thomas Phlips (ORCID: https://orcid.org/0000-0002-4303-9226)
• Gediminas Račkauskas (ORCID: https://orcid.org/0000-0003-3272-4380)
• Johan M. Vijgen (ORCID: https://orcid.org/0000-0003-4928-4836)
• Benjamin Berte (ORCID: https://orcid.org/0000-0002-2224-7448)
• Martin Huth Ruwald (ORCID: https://orcid.org/0000-0002-1541-309X)
• Tom J. R. De Potter (ORCID: https://orcid.org/0000-0003-1424-114X)
• Douglas S. Scherr (ORCID: https://orcid.org/0000-0001-5868-5493)
• Jim Hansen (ORCID: https://orcid.org/0000-0001-6600-9006)
• Sébastien Knecht (ORCID: https://orcid.org/0000-0003-4500-0146)
• Hugo Van Herendael (ORCID: https://orcid.org/0000-0001-9603-2370)
• Γεώργιος Κόλλιας (ORCID: https://orcid.org/0000-0001-8769-9157)
• Mads Brix Kronborg (ORCID: https://orcid.org/0000-0003-1672-222X)
• Mattias Francis Duytschaever (ORCID: https://orcid.org/0000-0001-8451-0013)
• Gábor Széplaki (ORCID: https://orcid.org/0000-0003-3795-1240)
• Tuantuan Tan
• Peter Lukáč (ORCID: https://orcid.org/0000-0003-4584-6184)

Institutions

• University of Copenhagen (DK)
• Johnson & Johnson (United States) (US)
• Royal College of Surgeons in Ireland (IE)
• Vilnius University (LT)
• Medical University of Graz (AT)
• Aarhus University Hospital (DK)
• Gentofte Hospital (DK)
• Jessa Hospital (BE)
• Onze Lieve Vrouwziekenhuis Hospital (BE)
• AZ Sint-Jan (BE)
• Krankenhaus der Elisabethinen (AT)
• Mater Private Hospital (AU)
• Cardiovascular Research Center (BR)
• Hirslanden Klinik St. Anna (CH)
• Ziekenhuis Oost-Limburg (BE)
• Vilnius University Hospital Santariskiu Klinikos (LT)

Publication Details

Journal

EP Europace

Published

2025-08-09

DOI

https://doi.org/10.1093/europace/euaf174

Citations

5

Primary Topic

Atrial Fibrillation Management and Outcomes

Type

article

Field-Weighted Citation Impact

6.94

Funders

• Bristol-Myers Squibb
• Pfizer
• Boston Scientific Corporation
• Biosense Webster
• Daiichi Sankyo Europe